allopregnanolone naturally occurring neurosteroid made body hormone medication allopregnanolone referred brexanolone sold brand name used treat postpartum given injection side effects brexanolone may include sedation sleepiness dry mouth hot flashes loss neurosteroid acts positive allosteric modulator gabaa receptor major biological target inhibitory neurotransmitter γaminobutyric acid brexanolone approved medical use united states us food drug administration fda considers firstinclass long administration time well cost onetime treatment raised concerns accessibility many brexanolone used treat postpartum depression adult women administered continuous intravenous infusion period women experiencing moderate severe postpartum depression treated single dose intravenous brexanolone display significant reduction hamd scores improvement still observed days side effects brexanolone include dizziness sedation headache nausea dry mouth loss consciousness flushing produce euphoria degree similar alprazolam infusion doses μg onehour serious severe adverse effects rare may include altered state consciousness syncope presyncope fatigue allopregnanolone possesses wide variety effects including particular order antidepressant anxiolytic stressreducing sedative cognitive memoryimpairment anesthetic anticonvulsant neuroprotective neurogenic fluctuations levels allopregnanolone neurosteroids seem play important role pathophysiology mood anxiety premenstrual syndrome catamenial epilepsy various neuropsychiatric pregnancy allopregnanolone pregnanolone involved sedation anesthesia allopregnanolone metabolic intermediate androgen backdoor pathway progesterone dihydrotestosterone occurs normal male fetus development placental progesterone male fetus feedstock pathway deficiencies pathway lead insufficient virilization male allopregnanolone endogenous inhibitory pregnane made pregnenolone positive allosteric modulator action γaminobutyric acid gaba gabaa allopregnanolone effects similar positive allosteric modulators gaba action gabaa receptor benzodiazepines including anxiolytic sedative anticonvulsant endogenously produced allopregnanolone exerts neurophysiological role finetuning gabaa receptor modulating action several positive allosteric modulators agonists gabaa allopregnanolone acts highly potent positive allosteric modulator gabaa allopregnanolone like inhibitory neurosteroids thdoc positively modulates gabaa receptor isoforms isoforms containing δ subunits exhibit greatest allopregnanolone also found act positive allosteric modulator gabaaρ receptor though implications action addition actions gaba receptors allopregnanolone like progesterone known negative allosteric modulator nach also appears act negative allosteric modulator along inhibitory neurosteroids allopregnanolone appears little action ligandgated ion channels including nmda ampa kainate glycine unlike progesterone allopregnanolone inactive classical nuclear progesterone receptor however allopregnanolone intracellularly oxidized act agonist pr reason allopregnanolone produce prmediated progestogenic reduced produce allopregnanolone progesterone reduced produce addition allopregnanolone reported agonist membrane progesterone receptors mprs discovered shortly including mprδ mprα mprβ activity receptors magnitude potent gabaa action allopregnanolone receptors may related part neuroprotective antigonadotropic also like progesterone recent evidence shown allopregnanolone activator pregnane x similarly many gabaa receptor positive allosteric modulators allopregnanolone found act inhibitor ltype voltagegated calcium channels including subtypes however threshold concentration allopregnanolone inhibit lvgccs determined μm nm far greater concentration nm estimated naturally produced human thus inhibition lvgccs unlikely actual significance effects endogenous also allopregnanolone along several neurosteroids found activate g proteincoupled bile acid receptor however able micromolar concentrations similarly case lvgccs far greater low nanomolar concentrations allopregnanolone estimated present increased levels allopregnanolone produce paradoxical effects including negative mood anxiety irritability appears allopregnanolone possesses biphasic ushaped actions gabaa receptor moderate level increases range nmoll total allopregnanolone approximately equivalent luteal phase levels inhibit activity receptor lower higher concentration increases stimulate seems common effect many gabaa receptor positive allosteric accordance acute administration low doses micronized progesterone reliably elevates allopregnanolone levels found negative effects mood higher doses neutral mechanism neurosteroid gabaa receptor pams like brexanolone antidepressant effects gabaa receptor pams benzodiazepines thought antidepressants proven although alprazolam historically prescribed neurosteroid gabaa receptor pams known interact gabaa receptors subpopulations differently gabaa receptorpotentiating neurosteroids may preferentially target gabaa receptors enhance tonic phasic inhibition mediated gabaa possible neurosteroids like allopregnanolone may act targets including membrane progesterone receptors ttype voltagegated calcium channels others mediate antidepressant brexanolone low oral bioavailability less necessitating nonoral volume distribution brexanolone approximately plasma protein binding brexanolone metabolized ketoreduction mediated via aldoketo compound conjugated glucuronidation via glucuronosyltransferases sulfation via metabolized significantly cytochrome three main metabolites brexanolone elimination halflife brexanolone nine total plasma clearance excreted feces less excreted unchanged allopregnanolone pregnane steroid also known closely related structurally progesterone isomers pregnanedione isomers isomers pregnanediol addition allopregnanolone one four isomers pregnanolone three isomers pregnanolone isopregnanolone epipregnanolone biosynthesis allopregnanolone brain starts conversion progesterone dehydrogenase converts intermediate allopregnanolone brain produced cortical hippocampus pyramidal neurons pyramidallike neurons basolateral variety synthetic derivatives analogues allopregnanolone similar activity effects exist including alfadolone alfaxolone ganaxolone hydroxydione minaxolone org org methanesulfonate renanolone derivative compound tetrahydrodeoxycorticosterone endogenous inhibitory neurosteroid similar properties allopregnanolone analogue allopregnanolone ganaxolone development treat epilepsy conditions including posttraumatic stress march brexanolone approved united states treatment postpartum depression ppd adult first drug approved us food drug administration fda specifically efficacy brexanolone shown two clinical studies participants received continuous intravenous infusion brexanolone placebo followed four fda approved allopregnanolone based evidence three clinical trials conducted united states trial trial trial women moderate severe postpartum fda granted application brexanolone priority review breakthrough therapy designations granted approval zulresso sage therapeutics allopregnanolone name molecule commonly used literature discussed endogenous neurosteroidcitation needed brexanolone international nonproprietary name united states adopted name context use zulresso brand name united states brexanolone schedule iv controlled brexanolone aqueous mixture synthetic allopregnanolone sulfobutyl ether βcyclodextrin betadex sulfobutyl ether sodium solubilizing provided allopregnanolone concentration ml mgml singledose vials use intravenous ml brexanolone solution contains mg allopregnanolone mg sulfobutyl ether βcyclodextrin mg citric acid monohydrate mg sodium citrate dihydrate water solution hypertonic must diluted target concentration mgml sterile water sodium chloride prior five infusion bags generally required full five infusion bags necessary patients weighing kg brexanolone development intravenously administered medication treatment major depressive disorder superrefractory status epilepticus essential tremor development indications suggested allopregnanolone precursor pregnenolone may therapeutic potential treatment various symptoms alcohol use disorders restoring deficits gabaergic inhibition moderating corticotropin releasing factor crf signaling inhibiting excessive neuroimmune activation many cooccurring symptoms ethanol addiction eg anxiety depression seizures sleep disturbance pain believed contribute downward spiral addiction may also controlled neuroactive exogenous progesterone oral progesterone elevates allopregnanolone levels body good dosetoserum level due suggested oral progesterone could described prodrug sorts result interest using oral progesterone treat catamenial well menstrual cyclerelated neurosteroidassociated conditions addition oral progesterone oral pregnenolone also found act prodrug though also pregnenolone animal models traumatic brain injury allopregnanolone shown reduce inflammation attenuating production proinflammatory cytokines tnfα h injury also shown reduce severity brain damage improve cognitive function httpsenwikipediaorgwikiallopregnanolone